Research progress in immune-related liver injury caused by immune checkpoint inhibitors / 国际生物医学工程杂志
International Journal of Biomedical Engineering
;
(6): 169-174, 2023.
Artículo
en Chino
| WPRIM
| ID: wpr-989334
ABSTRACT
In recent years, immune checkpoint inhibitors (ICIs) have made great progress in the treatment of tumor patients, prolonging their survival. However, the expansion of immunity against tumors with ICIs may also cause an imbalance in immune tolerance, leading to immune-related adverse events (irAEs). Immune-mediated liver injury caused by ICIs (ILICI) is one of the more common types of irAEs. In this review paper, the definition, epidemiology, risk factors, pathogenesis, pathology, clinical manifestations, treatment, recurrence, and re-treatment of ILICI were summarized to provide a basis for clinical diagnosis and treatment.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
International Journal of Biomedical Engineering
Año:
2023
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS